Seeking individuals ages 16-40 with Schizophrenia, Schizophreniform or Bipolar Disorder to complete a 16-week medication study
The purpose of the Enlighten Early study is to measure the effects of a new medication called ALKS 3831 on body weight in young adults with Schizophrenia, Schizophreniform or Bipolar Disorder.
Ipcs is a new device study for severe treatment resistant depression (TRD) - accepting applicants ages 21-80 years
Ipcs a research study looking at the safety and efficacy of intracalvarial prefrontal cortical stimulation in treatment resistant depressed (TRD) persons. Enrollment is open.
Seeking older adults (ages 60-85) with depression to complete a 6-week study
This study will examine whether an intervention using magnets called intermittent Theta Burst Stimulation (iTBS) alleviates depression and improves people’s ability to plan, make decisions and take action.
Improving treatment for adults 60+ who are currently depressed and taking antidepressant medication
Optimum is a research study to find out which medications work best and are safest for individuals who are 60+.